Advertisement

Approach to Salivary Gland Cytology

  • Min En NgaEmail author
Chapter
  • 4 Downloads

Abstract

Salivary gland cytology is a complex area, with some inherent limitations and challenges. This chapter briefly outlines the Milan System for Reporting Salivary Gland Cytology and provides an outline of the common and important entities encountered in salivary gland FNAs. It highlights the neoplasms that cytology can and cannot diagnose.

The morphologic discussion centres around four common cell types seen in salivary gland neoplasms—basaloid, oncocytic, clear cell and spindle. The spectrum of differentials will be presented, and discussion will also occur in tandem with specific stromal appearances.

Several particularly challenging areas are also elaborated on cystic lesions, basaloid lesions and others. Finally, specific pitfalls in salivary gland cytology are presented, along with practical tips and clues.

References

  1. 1.
    El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ, editors. WHO classification of head and neck tumours. 4th ed. Lyon: International Agency for Research on Cancer; 2017. 347 p. (World Health Organization classification of tumours).Google Scholar
  2. 2.
    Rossi ED, Baloch Z, Pusztaszeri M, Faquin WC. The Milan System for Reporting Salivary Gland Cytopathology (MSRSGC): an ASC-IAC-sponsored system for reporting salivary gland fine-needle aspiration. J Am Soc Cytopathol. 2018;7(3):111–8.PubMedCrossRefGoogle Scholar
  3. 3.
    Faquin WC, Rossi ED, Baloch Z, Barkan GA, Foschini M, Kurtycz DFI, et al., editors. The Milan System for Reporting Salivary Gland Cytopathology [Internet]. Springer International Publishing; 2018 [cited 2019 May 31]. https://www.springer.com/gp/book/9783319712840.
  4. 4.
    Farahani SJ, Baloch Z. Retrospective assessment of the effectiveness of the Milan System for Reporting Salivary Gland Cytology: a systematic review and meta-analysis of published literature. Diagn Cytopathol. 2019;47(2):67–87.PubMedCrossRefGoogle Scholar
  5. 5.
    Layfield LJ, Baloch ZW, Hirschowitz SL, Rossi ED. Impact on clinical follow-up of the Milan System for Salivary Gland Cytology: a comparison with a traditional diagnostic classification. Cytopathology. 2018;29(4):335–42.PubMedCrossRefGoogle Scholar
  6. 6.
    Wu HH, Alruwaii F, Zeng B-R, Cramer HM, Lai C-R, Hang J-F. Application of the Milan System for Reporting Salivary Gland Cytopathology: a retrospective 12-year bi-institutional study. Am J Clin Pathol. 2019;151(6):613–21.PubMedCrossRefGoogle Scholar
  7. 7.
    Liu H, Ljungren C, Lin F, Zarka MA, Chen L. Analysis of histologic follow-up and risk of malignancy for salivary gland neoplasm of uncertain malignant potential proposed by the Milan System for Reporting Salivary Gland Cytopathology: ROM for salivary gland NUMP. Cancer Cytopathol. 2018;126(7):490–7.PubMedCrossRefGoogle Scholar
  8. 8.
    Pujani M, Chauhan V, Agarwal C, Raychaudhuri S, Singh K. A critical appraisal of the Milan System for Reporting Salivary Gland Cytology (MSRSGC) with histological correlation over a 3-year period: Indian scenario. Diagn Cytopathol. 2019;47(5):382–8.PubMedCrossRefGoogle Scholar
  9. 9.
    Rohilla M, Singh P, Rajwanshi A, Gupta N, Srinivasan R, Dey P, et al. Three-year cytohistological correlation of salivary gland FNA cytology at a tertiary center with the application of the Milan System for Risk Stratification: salivary gland FNA: Milan System. Cancer Cytopathol. 2017;125(10):767–75.PubMedCrossRefGoogle Scholar
  10. 10.
    Song SJ, Shafique K, Wong LQ, LiVolsi VA, Montone KT, Baloch Z. The utility of the Milan System as a Risk Stratification tool for salivary gland fine needle aspiration cytology specimens. Cytopathology. 2019;30(1):91–8.PubMedCrossRefGoogle Scholar
  11. 11.
    Viswanathan K, Sung S, Scognamiglio T, Yang GCH, Siddiqui MT, Rao RA. The role of the Milan System for Reporting Salivary Gland Cytopathology: a 5-year institutional experience: Milan Classification System for Salivary Gland. Cancer Cytopathol. 2018;126(8):541–51.PubMedCrossRefGoogle Scholar
  12. 12.
    Vallonthaiel AG, Kaushal S, Jangir H, Rajendran HK. Application of the Milan System for Risk Stratification and its comparison with a previous reporting system of parotid gland cytopathology in a tertiary care centre. Acta Cytol. 2018;62(5–6):352–9.PubMedCrossRefGoogle Scholar
  13. 13.
    Pitman MB, Centeno BA, Ali SZ, Genevay M, Stelow E, Mino-Kenudson M, et al. Standardized terminology and nomenclature for pancreatobiliary cytology: the Papanicolaou Society of Cytopathology guidelines. Diagn Cytopathol. 2014;42(4):338–50.PubMedCrossRefGoogle Scholar
  14. 14.
    Avadhani V, Cohen C, Siddiqui MT. PLAG1: an immunohistochemical marker with limited utility in separating pleomorphic adenoma from other basaloid salivary gland tumors. Acta Cytol. 2016;60(3):240–5.PubMedCrossRefGoogle Scholar
  15. 15.
    Abd Raboh NM, Hakim SA. Diagnostic role of DOG1 and p63 immunohistochemistry in salivary gland carcinomas. Int J Clin Exp Pathol. 2015;8(8):9214–22.PubMedPubMedCentralGoogle Scholar
  16. 16.
    Skalova A, Michal M, Simpson RH. Newly described salivary gland tumors. Mod Pathol. 2017;30(s1):S27–43.PubMedCrossRefGoogle Scholar
  17. 17.
    Al-Husseinawi E, Hamidpour S, Omoscharka E. Mammary analogue secretory carcinoma of salivary gland diagnosed on submandibular gland cytology: a case report and review of the literature. Cytopathology. 2019;30(3):318–22.PubMedCrossRefGoogle Scholar
  18. 18.
    Kim YA, Joung JW, Lee S-J, Oh H-K, Cho CH, Sung WJ. Cytopathologic features of secretory carcinoma of salivary gland: report of two cases. J Pathol Transl Med. 2019;53(1):70–4.PubMedCrossRefGoogle Scholar
  19. 19.
    Pan-Trk immunohistochemistry is a sensitive and specific ancillary tool in diagnosing secretory carcinoma of salivary gland and detecting ETV6-NTRK…—PubMed—NCBI [Internet]. [cited 2019 Oct 10]. https://www.ncbi.nlm.nih.gov/pubmed/31448442.
  20. 20.
    Pusztaszeri MP, Faquin WC. Update in salivary gland cytopathology: recent molecular advances and diagnostic applications. Semin Diagn Pathol. 2015;32(4):264–74.PubMedCrossRefGoogle Scholar
  21. 21.
    Lee JH, Kang HJ, Yoo CW, Park WS, Ryu JS, Jung Y-S, et al. PLAG1, SOX10, and Myb expression in benign and malignant salivary gland neoplasms. J Pathol Transl Med. 2019;53(1):23–30.PubMedCrossRefGoogle Scholar
  22. 22.
    Mino M. Expression of KIT (CD117) in neoplasms of the head and neck: an ancillary marker for adenoid cystic carcinoma. Mod Pathol. 2003;16(12):1224–31.PubMedCrossRefGoogle Scholar
  23. 23.
    Chandan VS, Wilbur D, Faquin WC, Khurana KK. Is c-kit (CD117) immunolocalization in cell block preparations useful in the differentiation of adenoid cystic carcinoma from pleomorphic adenoma? Cancer Cytopathol. 2004;102(4):207–9.CrossRefGoogle Scholar
  24. 24.
    Ohtomo R, Mori T, Shibata S, Tsuta K, Maeshima AM, Akazawa C, et al. SOX10 is a novel marker of acinus and intercalated duct differentiation in salivary gland tumors: a clue to the histogenesis for tumor diagnosis. Mod Pathol. 2013;26(8):1041–50.PubMedCrossRefGoogle Scholar
  25. 25.
    Hsieh M-S, Lee Y-H, Chang Y-L. SOX10-positive salivary gland tumors: a growing list, including mammary analogue secretory carcinoma of the salivary gland, sialoblastoma, low-grade salivary duct carcinoma, basal cell adenoma/adenocarcinoma, and a subgroup of mucoepidermoid carcinoma. Hum Pathol. 2016;56:134–42.PubMedCrossRefGoogle Scholar
  26. 26.
    Brill LB, Kanner WA, Fehr A, Andrén Y, Moskaluk CA, Löning T, et al. Analysis of MYB expression and MYB-NFIB gene fusions in adenoid cystic carcinoma and other salivary neoplasms. Mod Pathol. 2011;24(9):1169–76.PubMedCrossRefGoogle Scholar
  27. 27.
    Rooney SL, Robinson RA. Immunohistochemical expression of MYB in salivary gland basal cell adenocarcinoma and basal cell adenoma. J Oral Pathol Med. 2017;46(9):798–802.PubMedCrossRefGoogle Scholar
  28. 28.
    Projetti F, Lacroix-Triki M, Serrano E, Vergez S, Barres BH, Meilleroux J, et al. A comparative immunohistochemistry study of diagnostic tools in salivary gland tumors: usefulness of mammaglobin, gross cystic disease fluid protein 15, and p63 cytoplasmic staining for the diagnosis of mammary analog secretory carcinoma? J Oral Pathol Med. 2015;44(4):244–51.PubMedCrossRefGoogle Scholar
  29. 29.
    Soares CD, de Lima Morais TM, Carlos R, Martins MD, de Almeida OP, Mariano FV, et al. Immunohistochemical expression of mammaglobin in salivary duct carcinomas de novo and salivary duct carcinoma ex pleomorphic adenoma. Hum Pathol. 2019;92:59–66.PubMedCrossRefGoogle Scholar
  30. 30.
    Layfield LJ, Gopez EV. Cystic lesions of the salivary glands: cytologic features in fine-needle aspiration biopsies. Diagn Cytopathol. 2002;27(4):197–204.PubMedCrossRefGoogle Scholar
  31. 31.
    Cibas ES, Ducatman BS. Cytology: diagnostic principles and clinical correlates [Internet]. 2014; [cited 2019 Jul 9]. http://www.clinicalkey.com/dura/browse/bookChapter/3-s2.0-C20110071892.
  32. 32.
    Pantanowitz L, Thompson LDR, Rossi ED. Diagnostic approach to fine needle aspirations of cystic lesions of the salivary gland. Head Neck Pathol. 2018;12(4):548–61.PubMedPubMedCentralCrossRefGoogle Scholar
  33. 33.
    Klijanienko J, Vielh P. Fine-needle sampling of salivary gland lesions. VII. Cytology and histology correlation of five cases of epithelial-myoepithelial carcinoma. Diagn Cytopathol. 1998;19(6):405–9.PubMedCrossRefGoogle Scholar
  34. 34.
    Kawahara A, Harada H, Yokoyama T, Kage M. p63 expression of clear myoepithelial cells in epithelial-myoepithelial carcinoma of the salivary gland: a useful marker for naked myoepithelial cells in cytology. Cancer. 2005;105(4):240–5.PubMedCrossRefGoogle Scholar
  35. 35.
    Hang J-F, Shum CH, Ali SZ, Bishop JA. Cytological features of the Warthin-like variant of salivary mucoepidermoid carcinoma. Diagn Cytopathol. 2017;45(12):1132–6.PubMedCrossRefGoogle Scholar
  36. 36.
    Garrett SL, Trott K, Sebastiano C, Wolf MJ, Rao NK, Curry JM, et al. Sensitivity of fine-needle aspiration and imaging modalities in the diagnosis of low-grade mucoepidermoid carcinoma of the parotid gland. Ann Otol Rhinol Laryngol. 2019;128(8):755–9.PubMedCrossRefGoogle Scholar
  37. 37.
    Miller JA, An D, Shafique K, Song S, Rao RA, Viswanathan K, et al. Mucoepidermoid carcinoma, acinic cell carcinoma, and adenoid cystic carcinoma on fine-needle aspiration biopsy and the Milan System: an international multi-institutional study. J Am Soc Cytopathol. 2019;8(5):270–7.PubMedCrossRefGoogle Scholar
  38. 38.
    Daneshbod Y, Daneshbod K, Khademi B. Diagnostic difficulties in the interpretation of fine needle aspirate samples in salivary lesions. Acta Cytol. 2009;53(1):53–70.PubMedCrossRefGoogle Scholar
  39. 39.
    Khademi B, Kazemi T, Bayat A, Bahranifard H, Daneshbod Y, Mohammadianpanah M. Salivary gland myoepithelial neoplasms. Acta Cytol. 2010;54(6):1111–7.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2021

Authors and Affiliations

  1. 1.Department of PathologyNational University HospitalSingaporeSingapore

Personalised recommendations